Intuitive Surgical, Inc. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Intuitive Surgical, Inc. (ISRG) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $1.11 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-07-21
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-06-30 was $523.70M, a 53.98% increase year-over-year.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-03-31 was $582.30M, a 31.49% decline year-over-year.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $380.00M, a 20.63% decline year-over-year.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $605.50M, a 19.81% decline year-over-year.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $2.18B, a 24.43% decline from fiscal 2024.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $2.88B, a 7.01% increase from fiscal 2023.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $2.69B, a 17.34% decline from fiscal 2022.
- Intuitive Surgical, Inc. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $3.25B, a 23.75% decline from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $523.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $1.11B 10-Q · filed 2026-07-21 | $1.49B derived: sum of 3 quarters · filed 2026-07-21 | $2.09B derived: sum of 4 quarters · filed 2026-07-21 |
| 2026-03-31 | $582.30M 10-Q · filed 2026-04-22 | $962.30M derived: sum of 2 quarters · filed 2026-04-22 | $1.57B derived: sum of 3 quarters · filed 2026-04-22 | $1.91B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-12-31 | $380.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $985.50M derived: sum of 2 quarters · filed 2026-02-03 | $1.33B derived: sum of 3 quarters · filed 2026-07-21 | $2.18B 10-K · filed 2026-02-03 |
| 2025-09-30 | $605.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $945.60M derived: sum of 2 quarters · filed 2026-07-21 | $1.80B 10-Q · filed 2025-10-22 | $2.27B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-06-30 | $340.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21 | $1.19B 10-Q · filed 2026-07-21 | $1.67B derived: sum of 3 quarters · filed 2026-07-21 | $2.42B derived: sum of 4 quarters · filed 2026-07-21 |
| 2025-03-31 | $849.90M 10-Q · filed 2026-04-22 | $1.33B derived: sum of 2 quarters · filed 2026-04-22 | $2.08B derived: sum of 3 quarters · filed 2026-04-22 | $2.81B derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $478.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.23B derived: sum of 2 quarters · filed 2026-02-03 | $1.96B derived: sum of 3 quarters · filed 2026-02-03 | $2.88B 10-K · filed 2026-02-03 |
| 2024-09-30 | $755.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $1.48B derived: sum of 2 quarters · filed 2025-10-22 | $2.40B 10-Q · filed 2025-10-22 | $3.00B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $725.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23 | $1.64B 10-Q · filed 2025-07-23 | $2.24B derived: sum of 3 quarters · filed 2026-02-03 | $2.85B derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $919.10M 10-Q · filed 2025-04-23 | $1.52B derived: sum of 2 quarters · filed 2026-02-03 | $2.12B derived: sum of 3 quarters · filed 2026-02-03 | $2.86B derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $597.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.20B derived: sum of 2 quarters · filed 2026-02-03 | $1.95B derived: sum of 3 quarters · filed 2026-02-03 | $2.69B 10-K · filed 2026-02-03 |
| 2023-09-30 | $605.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-18 | $1.35B derived: sum of 2 quarters · filed 2024-10-18 | $2.09B 10-Q · filed 2024-10-18 | $2.81B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-06-30 | $742.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19 | $1.49B 10-Q · filed 2024-07-19 | $2.21B derived: sum of 3 quarters · filed 2025-01-31 | $2.88B derived: sum of 4 quarters · filed 2025-01-31 |
| 2023-03-31 | $744.40M 10-Q · filed 2024-04-19 | $1.46B derived: sum of 2 quarters · filed 2025-01-31 | $2.13B derived: sum of 3 quarters · filed 2025-01-31 | $2.93B derived: sum of 4 quarters · filed 2025-01-31 |
| 2022-12-31 | $718.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $1.39B derived: sum of 2 quarters · filed 2025-01-31 | $2.19B derived: sum of 3 quarters · filed 2025-01-31 | $3.25B 10-K · filed 2025-01-31 |
| 2022-09-30 | $671.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-20 | $1.47B derived: sum of 2 quarters · filed 2023-10-20 | $2.54B 10-Q · filed 2023-10-20 | $3.27B derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-06-30 | $797.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-24 | $1.87B 10-Q · filed 2023-07-24 | $2.60B derived: sum of 3 quarters · filed 2024-01-31 | $3.54B derived: sum of 4 quarters · filed 2024-01-31 |
| 2022-03-31 | $1.07B 10-Q · filed 2023-04-20 | $1.80B derived: sum of 2 quarters · filed 2024-01-31 | $2.74B derived: sum of 3 quarters · filed 2024-01-31 | $4.10B derived: sum of 4 quarters · filed 2024-01-31 |
| 2021-12-31 | $735.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $1.67B derived: sum of 2 quarters · filed 2024-01-31 | $3.04B derived: sum of 3 quarters · filed 2024-01-31 | $4.27B 10-K · filed 2024-01-31 |
| 2021-09-30 | $935.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21 | $2.30B derived: sum of 2 quarters · filed 2022-10-21 | $3.53B 10-Q · filed 2022-10-21 | $4.53B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $1.37B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $2.60B 10-Q · filed 2022-07-22 | $3.59B derived: sum of 3 quarters · filed 2023-02-10 | $4.23B derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $1.23B 10-Q · filed 2022-04-22 | $2.23B derived: sum of 2 quarters · filed 2023-02-10 | $2.86B derived: sum of 3 quarters · filed 2023-02-10 | $3.54B derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $997.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.63B derived: sum of 2 quarters · filed 2023-02-10 | $2.31B derived: sum of 3 quarters · filed 2023-02-10 | $2.93B 10-K · filed 2023-02-10 |
| 2020-09-30 | $634.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | $1.32B derived: sum of 2 quarters · filed 2021-10-20 | $1.93B 10-Q · filed 2021-10-20 | $2.47B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $681.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | $1.30B 10-Q · filed 2021-07-21 | $1.84B derived: sum of 3 quarters · filed 2022-02-03 | $2.45B derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $617.60M 10-Q · filed 2021-04-21 | $1.16B derived: sum of 2 quarters · filed 2022-02-03 | $1.77B derived: sum of 3 quarters · filed 2022-02-03 | $2.43B derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $541.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $1.15B derived: sum of 2 quarters · filed 2022-02-03 | $1.81B derived: sum of 3 quarters · filed 2022-02-03 | $2.57B 10-K · filed 2022-02-03 |
| 2019-09-30 | $609.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-19 | $1.27B derived: sum of 2 quarters · filed 2020-10-19 | $2.03B 10-Q · filed 2020-10-19 | $2.51B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $663.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $1.42B 10-Q · filed 2020-07-23 | $1.90B derived: sum of 3 quarters · filed 2021-02-10 | $2.23B derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $755.10M 10-Q · filed 2020-04-17 | $1.24B derived: sum of 2 quarters · filed 2021-02-10 | $1.56B derived: sum of 3 quarters · filed 2021-02-10 | $1.99B derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $484.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $808.70M derived: sum of 2 quarters · filed 2021-02-10 | $1.23B derived: sum of 3 quarters · filed 2021-02-10 | $1.53B 10-K · filed 2021-02-10 |
| 2018-09-30 | $323.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-18 | $747.90M derived: sum of 2 quarters · filed 2019-10-18 | $1.05B 10-Q · filed 2019-10-18 | $1.30B derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-06-30 | $424.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22 | $724.90M 10-Q · filed 2019-07-22 | $977.30M derived: sum of 3 quarters · filed 2020-02-07 | $1.13B derived: sum of 4 quarters · filed 2020-02-07 |
| 2018-03-31 | $300.80M 10-Q · filed 2019-04-19 | $553.20M derived: sum of 2 quarters · filed 2020-02-07 | $709.00M derived: sum of 3 quarters · filed 2020-02-07 | $895.50M derived: sum of 4 quarters · filed 2020-02-07 |
| 2017-12-31 | $252.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $408.20M derived: sum of 2 quarters · filed 2020-02-07 | $594.70M derived: sum of 3 quarters · filed 2020-02-07 | $703.10M 10-K · filed 2020-02-07 |
| 2017-09-30 | $155.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22 | $342.30M derived: sum of 2 quarters · filed 2018-10-22 | $450.70M 10-Q · filed 2018-10-22 | $736.90M derived: sum of 4 quarters · filed 2019-02-04 |
| 2017-06-30 | $186.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-20 | $294.90M 10-Q · filed 2018-07-20 | $581.10M derived: sum of 3 quarters · filed 2019-02-04 | $837.90M derived: sum of 4 quarters · filed 2019-02-04 |
| 2017-03-31 | $108.40M 10-Q · filed 2018-04-18 | $394.60M derived: sum of 2 quarters · filed 2019-02-04 | $651.40M derived: sum of 3 quarters · filed 2019-02-04 | $837.60M derived: sum of 4 quarters · filed 2019-02-04 |
| 2016-12-31 | $286.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $543.00M derived: sum of 2 quarters · filed 2019-02-04 | $729.20M derived: sum of 3 quarters · filed 2019-02-04 | $970.10M 10-K · filed 2019-02-04 |
| 2016-09-30 | $256.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20 | $443.00M derived: sum of 2 quarters · filed 2017-10-20 | $683.90M 10-Q · filed 2017-10-20 | $934.20M derived: sum of 4 quarters · filed 2018-02-02 |
| 2016-06-30 | $186.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21 | $427.10M 10-Q · filed 2017-07-21 | $677.40M derived: sum of 3 quarters · filed 2018-02-02 | $850.40M derived: sum of 4 quarters · filed 2018-02-02 |
| 2016-03-31 | $240.90M 10-Q · filed 2017-04-19 | $491.20M derived: sum of 2 quarters · filed 2018-02-02 | $664.20M derived: sum of 3 quarters · filed 2018-02-02 | $927.20M derived: sum of 4 quarters · filed 2018-02-02 |
| 2015-12-31 | $250.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $423.30M derived: sum of 2 quarters · filed 2018-02-02 | $686.30M derived: sum of 3 quarters · filed 2018-02-02 | $825.80M 10-K · filed 2018-02-02 |
| 2015-09-30 | $173.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19 | $436.00M derived: sum of 2 quarters · filed 2016-10-19 | $575.50M 10-Q · filed 2016-10-19 | $737.00M derived: sum of 4 quarters · filed 2017-02-06 |
| 2015-06-30 | $263.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | $402.50M 10-Q · filed 2016-07-20 | $564.00M derived: sum of 3 quarters · filed 2017-02-06 | $694.50M derived: sum of 4 quarters · filed 2017-02-06 |
| 2015-03-31 | $139.50M 10-Q · filed 2016-04-19 | $301.00M derived: sum of 2 quarters · filed 2017-02-06 | $431.50M derived: sum of 3 quarters · filed 2017-02-06 | $659.00M derived: sum of 4 quarters · filed 2017-02-06 |
| 2014-12-31 | $161.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $292.00M derived: sum of 2 quarters · filed 2017-02-06 | $519.50M derived: sum of 3 quarters · filed 2017-02-06 | $714.70M 10-K · filed 2017-02-06 |
| 2014-09-30 | $130.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $358.00M derived: sum of 2 quarters · filed 2015-10-21 | $553.20M 10-Q · filed 2015-10-21 | $725.80M derived: sum of 4 quarters · filed 2016-02-02 |
| 2014-06-30 | $227.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22 | $422.70M 10-Q · filed 2015-07-22 | $595.30M derived: sum of 3 quarters · filed 2016-02-02 | $804.00M derived: sum of 4 quarters · filed 2016-02-02 |
| 2014-03-31 | $195.20M 10-Q · filed 2015-04-22 | $367.80M derived: sum of 2 quarters · filed 2016-02-02 | $576.50M derived: sum of 3 quarters · filed 2016-02-02 | $822.90M derived: sum of 4 quarters · filed 2016-02-02 |
| 2013-12-31 | $172.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $381.30M derived: sum of 2 quarters · filed 2016-02-02 | $627.70M derived: sum of 3 quarters · filed 2016-02-02 | $822.40M 10-K · filed 2016-02-02 |
| 2013-09-30 | $208.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23 | $455.10M derived: sum of 2 quarters · filed 2014-10-23 | $649.80M 10-Q · filed 2014-10-23 | $880.90M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-06-30 | $246.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $441.10M 10-Q · filed 2014-07-24 | $672.20M derived: sum of 3 quarters · filed 2015-02-06 | $916.50M derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-03-31 | $194.70M 10-Q · filed 2014-04-25 | $425.80M derived: sum of 2 quarters · filed 2015-02-06 | $670.10M derived: sum of 3 quarters · filed 2015-02-06 | $841.70M derived: sum of 4 quarters · filed 2015-02-06 |
| 2012-12-31 | $231.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $475.40M derived: sum of 2 quarters · filed 2015-02-06 | $647.00M derived: sum of 3 quarters · filed 2015-02-06 | $800.20M 10-K · filed 2015-02-06 |
| 2012-09-30 | $244.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-18 | $415.90M derived: sum of 2 quarters · filed 2013-10-18 | $569.10M 10-Q · filed 2013-10-18 | $728.90M derived: sum of 4 quarters · filed 2014-02-03 |
| 2012-06-30 | $171.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-22 | $324.80M 10-Q · filed 2013-07-22 | $484.60M derived: sum of 3 quarters · filed 2014-02-03 | $623.50M derived: sum of 4 quarters · filed 2014-02-03 |
| 2012-03-31 | $153.20M 10-Q · filed 2013-04-19 | $313.00M derived: sum of 2 quarters · filed 2014-02-03 | $451.90M derived: sum of 3 quarters · filed 2014-02-03 | $662.70M derived: sum of 4 quarters · filed 2014-02-03 |
| 2011-12-31 | $159.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $298.70M derived: sum of 2 quarters · filed 2014-02-03 | $509.50M derived: sum of 3 quarters · filed 2014-02-03 | $691.80M 10-K · filed 2014-02-03 |
| 2011-09-30 | $138.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-18 | $349.70M derived: sum of 2 quarters · filed 2012-10-18 | $532.00M 10-Q · filed 2012-10-18 | |
| 2011-06-30 | $210.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-23 | $393.10M 10-Q · filed 2012-07-23 | ||
| 2011-03-31 | $182.30M 10-Q · filed 2012-04-19 | |||
| 2010-12-31 | $397.80M 10-K · filed 2013-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |